IJGMP - RV Function Assessment Pre and Post PTMC in Patients With Severe - Autosaved

Download as pdf or txt
Download as pdf or txt
You are on page 1of 8

International Journal of General

Medicine and Pharmacy (IJGMP)


ISSN(P): 2319–3999; ISSN(E): 2319–4006
Vol. 8, Issue 5, Aug–Sep 2019; 37–44
© IASET

RV FUNCTION ASSESSMENT PRE AND POST PTMC IN PATIENTS WITH SEVERE


MITRAL STENOSIS

Shilpa Jayaprakash1 & Kishan Aralapuram2


1
Assistant Professor, Department of Cardiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research,
Bangalore, Karnataka, India
2
Assistant Professor, Institute of Nephrourology, Victoria Hospital Campus, Bengaluru, Karnataka, India

ABSTRACT

The purpose of this research paper is to assess the immediate and short term effect of PTMC on RV function using two
dimensional and doppler echocardiographic indices and also to assess the RV function in patients who undergo PTMC for
isolated severe mitral stenosis before, after and at 6 months cohort follow up after PTMC. Cohort prospective study
included adult patients who are > 18 years of age with isolated severe MS, in sinus rhythm, and cases were admitted for
the BMV. Exclusion criteria ; patients with atrial fibrillation, in accordance with NYHA class I or IV symptoms, overt right
heart failure, pregnancy, chronic obstructive pulmonary disease (COPD), other valvular lesions or undergoing emergency
BMV were excluded from the study. Present study consisted of 50 patients with isolated severe MS in sinus rhythm, who
met the inclusion criteria. The baseline characteristics of the study population is summarized in Table 1 Mean age of the
population studied was 38±9 yrs. 62% were females and 38% were males. RV Free wall thickness decreased from
0.51±0.11cm to 0.44±0.07 which was statistically not significant. RV dimensions decreased from baseline in basal, mid
and apex to base dimensions which was statistically not significant. RV systolic area decreased from 29.30±5.28cm2 to
25.18±4.40 cm2 at 6 months which was statistically not significant. RV diastolic area increased from 46.30±9.20 cm2 to
51.82±9.87cm2 at 6 months which was statistically significant (p<0.05). This study showed RV function parameters in
patients with severe mitral stenosis did not improve immediately after PTMC. However these parameters showed
improvement compared to baseline at 6 months of follow up.

KEYWORDS: RV Function, PTMC, Stenosis, Follow Up

Article History
Received: 12 Sep 2019 | Revised: 16 Sep 2019 | Accepted: 18 Sep 2019

INTRODUCTION

A right ventricular function plays an important role in the development of clinical symptoms and the overall prognosis of
patients with mitral stenosis [1–3]. The RV function is predominantly affected through hemodynamic changes due to
pulmonary vascular alterations. The right ventricular function is an important determinant of exercise capacity, survival
and postoperative outcome in patients with mitral stenosis [3]. RV functional assessment is difficult and not done routinely
because of its complex anatomy and high load dependence. Right ventricular functions cannot reliably be evaluated by
conventional echocardiography techniques because of asymmetrical shape (crescentic), narrow acoustic window, irregular
endocardial surface, complex contraction mechanism[5]. The problem is compounded by irregular trabeculations, a

www.iaset.us [email protected]
38 Shilpa Jayaprakash & Kishan Aralapuram

separate infundibulum, and variations in right ventricular shape with altered loading conditions[5]. The substernal right
ventricle is less accessible than the left ventricle and its dimensions more difficult to standardize. RV function is closely
related to symptoms, functional capacity, need and timing for interventions, perioperative mortality and postoperative
results in patients with MS[6]. In mild degree of MS, secondary pulmonary hypertension occurs due to reactive changes in
pulmonary vascular resistance. Although, it is reversible in mild MS, long standing severe MS is associated with fixed
pulmonary arteriolar constriction and obliterative changes in vascular bed, giving rise to significant RV afterload and RV
dysfunction[9]. Thus, RV dysfunction is an important indicator to evaluate the severity of MS. Radio nuclide ventriculo
graphy, cardiac catheterization; cardiac magnetic resonance imaging (MRI) and 3-dimensional echocardiography could be
used for the assessment of RV function. However, these methods are time consuming, costly and not widely available[5].
The purpose of this research paper is to assess the immediate and short term effect of PTMC on RV function using two
dimensional and doppler echocardiographic indices and also to assess the RV function in patients who undergo PTMC for
isolated severe mitral stenosis before, after and at 6 months cohort follow up after PTMC.

METHODS

Cohort prospective study included adult patients who are > 18 years of age with isolated severe MS, in sinus rhythm, and
cases were admitted for the BMV. Exclusion criteria ; patients with atrial fibrillation, in accordance with NYHA class I or
IV symptoms, overt right heart failure, pregnancy, chronic obstructive pulmonary disease (COPD), other valvular lesions
or undergoing emergency BMV were excluded from the study. Patients who developed more than mild mitral regurgitation
after BMV were also excluded from the study group. A total 50 cases with isolated severe mitral stenosis in sinus rhythm
with valve morphology suitable for PTMC were selected based on the regularity criteria of NYHA. A brief history, clinical
examination and relevant investigations were done at hospital.Echocardiographic measurements were done,the 2D echo
was performed before PTMC, after PTMC (within 48 hours) and at 6 months after PTMC using 3.5Hz probe in Philips
HD7 XR machine followed by 2 D Echo parameters were assessed simultaneously:All the measurements were performed
according to standard guidelines for assessment of right heart set by American society of echocardiography (ASE) [9]. For
Mitral valve orifice area, parasternal short axis view at the level of commissures was taken. MVOA was determined using
planimetry techniques. Mitral valve gradient was estimated in apical four chamber view using continuous wave doppler
across mitral valve. Mitral regurgitation was assessed in multiple views- apical four- chamber, apical-two chamber and
parasternal long axis views. Tricuspid regurgitation was determined in apical four- chamber view using continuous wave
doppler across tricuspid valve. The pulmonary artery systolic pressure was measured by adding RA pressure to TR jet and
also LV- EF was measured using modified Simpson’s disc summation method. RV free wall thickness was estimated in
sub costal four- chamber view using M- mode across tricuspid chordal level. RV dimensions were demonstrated at three
levels in end diastole. Further, the RV basal diameter is measured at the level of tricuspid annulus. RV mid diameter was
measured at the level of mid cavity. RV apex to base diameter was taken from RV apex to tricuspid annulus. Fractional
area change (FAC) is measured by tracing the RV endocardial borders at end diastole and end systole, taking care to
include RV apex and lateral wall. Trabeculations, leaflets and chords are included in the chamber. FAC is calculated based
on the following formula FAC = End diastolic area-End systolic area x 100
End diastolic area

Tricuspid annular motion (TAM) or Tricuspid annular plane systolic excursion (TAPSE) measures the
longitudinal shortening of RV based on the distance the tricuspid annulus moves towards the RV apex from end diastole to

Impact Factor (JCC): 5.9089 NAAS Rating 3.99


RV Function Assessment Pre and Post PTMC in Patients with Severe Mitral Stenosis 39

end systole. It is measured from M -mode intersecting the lateral tricuspid annulus from an RV optimized apical 4four-
chamber view. Myocardial performance index (MPI or Tei index) is the ratio of isovolumetric contraction (IVC) plus
isovolumetric relaxation (IVR) is divided by ejection time (ET). The MPI has been calculated based on tricuspid valve
closure time (TCO), which includes RV ejection time plus isovolumetric contraction and relaxation time. It is measured as
total duration of tricuspid regurgitation or as the interval between the end of tissue Doppler A’ velocity and onset of next
E’ velocity. Ejection time is measured as the tissue Doppler systolic velocity duration.MPI = (TCO-ET)/ET. Colour tissue
Doppler Imaging was used to measure systolic velocities in annular, basal, mid and apical regions. Cardiac catheterization
was done during PTMC and LA pressure and PA systolic pressure was measures before and after PTMC. Coronary
angiography was done in male patients over 40 years and females over 50 years or in presence of risk factors. Collected
data was analysed by R-open source statistical software,multivariate analysis was done for testing the hypothesis

RESULTS

Study group consisted of 50 patients with isolated severe MS in sinus rhythm, who met the inclusion criteria. The baseline
characteristics of the study population is summarized in Table 1 Mean age of the population studied was 38±9 yrs. 62%
were females and 38% were males. All patients had dyspnea on exertion. 56% were in NYHA Class II, 44% were in
NYHA Class III. Mean duration of symptoms was 11.9±3.6 months. Mean pulse rate was 77.9±8.7 bpm. Evidence of LA
enlargement on ECG was present in 74% of patients.

Table 1: Baseline Characteristics


Variables No (%)Mean±SD P-Value
Age 38.04±9.79 P≦0.001
M-19(38.00%)
Sex P≦0.001
F-31(62.00%)
II-28(56%) P≦0.001
NHYA Class
III-22(44%) P≦0.001
Duration of symptoms
11.93±3.63 P≦0.001
(in months)
Pulse rate(bpm) 77.96±8.72 P≦0.001
LAE on ECG 37(74.0%) P≦0.001

Table 2: Over View of Echocardiographic Parameters that were Assessed


Pre PTMC Pre PTMC Post PTMC
At 6 V/S Post V/S 6 V/S6
Parameters Pre PTMC Post PTMC
Months PTMC Months Months
P-Value P-Value P-Value
MVOA(cm2) 0.81±0.16 1.76±0.12 1.65±0.12 ≦0.001 ≦0.001 ≦0.001
MV Gradient
22.60±4.20 10.96±3.32 12.46±3.79 ≦0.001 ≦0.001 ≦0.001
Peak(mmHg)
MV Gradient
14.30±2.94 4.76±1.06 5.73±1.1 ≦0.001 ≦0.001 ≦0.001
Mean(mmHg)
TR Jet
Gradient 60.80±23.95 39.32±14.44 37.48±14.31 ≦0.001 ≦0.001 ≦0.001
(mmHg)
PASP(mmHg) 68.86±25.92 43.32±15.12 38.96±13.82 ≦0.001 ≦0.001 ≦0.001
LV EF% 59.76±0.59 59.60±0.76 59.80±0.57 ≧0.001 ≧0.001 ≧0.001

As per the research findings, the mean MVOA was 0.81±0.16 cm2 which increased to 1.76±0.12 cm2 post PTMC
and was 1.65±0.12cm2 at 6 months which was statistically significant (p<0.05). Peak MV gradient start down from

www.iaset.us [email protected]
40 Shilpa Jayaprakash & Kishan Aralapuram

22.60±4.20mm Hg to 10.96±3.32mm Hg after PTMC which was 12.46±3.79 mm Hg at 6 months which was statistically
significant (p<0.05). Mean
an MV gradient showed down from 14.30±2.94 mm Hg to 4.76±1.06mm Hg after PTMC which
was 5.73±1.1mmHg at 6 months which was statistically significant (p<0.05). TR Jet Gradient attained 60.80±23.95mm Hg to
39.32±14.44mm Hg after PTMC which was 37.48±14.31mmHg
37.48±14.31mmHg at 6 months which was statistically significant (p<0.05). The
mean PA Systolic pressure was 68.86±25.92mm Hg to 43.32±15.12mm Hg after PTMC which was 38.96±13.82 mm Hg at 6
months which was statistically significant (p<0.01). LV EF was 59.76±0.59% before PTMC, 59.60±0.76% after PTMC and
increased to 59.80±0.57% at 6 months follow up period (p>0.01) (table 1.2)

Figure 1: Mean Values of Pre and Post PTMC w Fith Different Time Period.
Period

Table 3: RV Function Parameters Assessed By 2D Echocardiography

Pre PTMC
Pre PTMC Post PTMC
Post At 6 V/S Post
Parameters Pre PTMC V/S 6 Months V/S6 Months
PTMC Months PTMC
P
P-Value P-Value
P-Value

RV Free wallthickness(cm) 0.51±0.11 0.51±0.11 0.44±0.07 0.34 0.38 0.44

RV dimensions(cm) Base 3.57±0.98 3.52±0.92 3.29±0.88 0.52 0.55 0.62

Mid 3.72±0.93 3.71±0.93 3.42±0.84 0.28 0.26 0.33


Apex to Base 6.71±0.97 6.66±0.94 6.28±0.95 0.38 0.36 0.34

RV Systolic area(cm2) 29.30±5.28 29.15±5.28 25.18±4.40 0.44 0.48 0.51

RV Diastolic area 46.30±9.20 46.21±9.20 51.82±9.87 0.11 0.18 0.00*


RV FAC% 35.75±9.96 35.97±9.85 50.75±7.02 0.36 0.32 0.00*

TAM(mm) 16.76±3.15 16.72±3.04 18.80±2.91 0.28 0.26 0.05*

MPI 0.65±0.08 0.63±0.07 0.45±0.07 0.18 0.20 0.02*


S velocity at annulus 4.71±0.71 4.68±0.62 4.98±0.65 0.33 0.34 0.38

Base 10.90±1.50 10.92±1.51 11.59±1.50 0.21 0.23 0.28

Mid 7.96±1.46 7.96±0.46 8.50±0.52 0.44 0.43 0.16


Apex 8.77±0.59 8.78±0.52 9.47±0.62 0.27 0.29 0.12

Impact Factor (JCC): 5.9089 NAAS Rating 3.99


RV Function Assessment Pre and Post PTMC in Patients
Pa with Severe Mitral Stenosis 41

*significant ‘p’ value


RV Free wall thickness decreased from 0.51±0.11cm to 0.44±0.07 which was statistically not significant. RV
dimensions decreased from baseline in basal, mid and apex to base dimensions which was statistically not significant. RV
systolic area decreased from 29.30±5.28cm2 to 25.18±4.40 cm2 at 6 months which was statistically not significant. RV
diastolic area increased from 46.30±9.20 cm2 to 51.82±9.87cm2 at 6 months which was statistically significant (p<0.05).
RV FAC increased from 35.75±9.96% at baseline to 50.75±7.02% at 6 months which was statistically significant (p<0.05).
(p<0.05
TAM increased from 16.76±3.15mm at baseline to 18.80±2.91mm at 6 months which was statistically significant (p=0.05).
MPI decreased from 0.65±0.08 at baseline to 0.45±0.07 at 6 months which was statistically significant (p=0.02). Systolic
velocity measured
red by tissue Doppler at annulus, base, mid and apex increased from baseline to 6 months which was not
statistically significant.

Figure 2: PTMC Associated Parameters Mean Values S.


S

Table 3: Cardiac Catheterization Data

Cardiac Catheterization Data Pre PTMC Post PTMC P--Value


Mean LA pressure (mmHg) 24.60±6.49 12.20±2.84 ≦0.0001*

PA systolic pressure (mmHg) 73.14±30.85 45.30±16.49 ≦0.0001*

Mean LA pressure reduced from 24mmHg to 12mmHg and mean PASP reduced from 73mmHg to 45mmHg after
PTMC, which was statistically significant (p<0.0001)

DISCUSSIONS

This was a prospective study which studied RV function in patients with severe mitral stenosis before, after and 6 months after
aft
PTMC. Our study showed that the RV systolic function is impaired in patients
patients with severe MS which correlates with earlier
hemodynamic and clinical studies.3,9,10. The cause of RV dysfunction is attributed to the increased RV afterload in these patients.
Left atrial hypertension in these patients leads to chronic pulmonary venous congestion, which ultimately leads to PH. This is
thought to be responsible for increased RV after load and subsequent RV dysfunction in these patients. However some authors
had suggested that the direct rheumatic involvement of the RV with resultant myocyte
myocyte necrosis, replacement fibrosis and
calcification is the explanation of such depressed myocardial function [11,12].The
[11,12].The right ventricular function plays an important
valvular disease of the left heart1. An increase
role as a determinant of symptoms, exercise capacity and survival in patients with valvular

www.iaset.us [email protected]
42 Shilpa Jayaprakash & Kishan Aralapuram

in pulmonary wedge pressure as a result of MS is associated with a rise in mean pulmonary artery pressure, increased afterload
and, consequently, a drop in right ventricular ejection fraction. The mean age of the study group was 38.04±9.79 yrs which is
comparable to other studies by S.N. Murthy Jayanthi Sriram et al [6]. and Vipin Kumar et al[]5. 62% of the study population was
female which is comparable to Inci et al7. NHYA Class II symptoms were seen in 56% of patients and NYHA Class III was seen
in 44% of patients which was comparable to Ahmad Noor et al study [8]. MVOA was 0.81±0.16cm2 pre PTMC which increased
to 1.76±0.12cm2 post PTMC, MV gradient came down from 22/14 to 11/5mm Hg which was comparable to study by A. Drighil
et al [16].Our study indicates that despite a rapid fall in pulmonary artery pressures concomitant with a significant increase in
mitral valve area following PTMC, right ventricular global function does not show significant improvement in the immediate
post-procedure period. RV FAC, TAM and MPI all showed statistically significant improvement in RV function after 6 months
of PTMC. This is attributable to slow reduction in PA pressure and decrease in RV afterload. Pulmonary artery pressure
decreases immediately after PTMC[8,18]. Pulmonary pressure usually normalises within six months, but may stay elevated for
more than two years in some patients [8]. This can be explained by the structural changes of the pulmonary vessels, which may
return only slowly after operation or may be irreversible. A normalisation of right ventricular ejection fraction, concurrent with a
normalisation of pulmonary artery pressure, has been reported in most patients after PTMC [2,3,5]. However, in some cases, the
right ventricular ejection fraction remains depressed. This is explained by the occurrence of myocardial dysfunction due to
rheumatic pathology[19,20] or high wall stress secondary to ventricular dilatation [17]. In the latter study, the right ventricular
ejection fraction normalised in only 19% of patients within three months following mitral valve replacement[17]. The extent of
right ventricular dilatation and the duration of chronic pressure overload beyond which complete normalization of right
ventricular function cannot be achieved is, however, not known. MPI (Tei index), which is calculated using three indices of time,
is a reliable parameter evaluating both systolic and diastolic functions [21]. The Tei index is not greatly influenced by
changes in blood pressure, afterload, heart rate, preload, RV pressure, dilatation, or tricuspid regurgitation in the clinical
setting. The study of Mohan et al [9].showed that pulmonary artery pressure decreased immediately after balloon
valvuloplasty and that right ventricular function, as assessed by the Tei index, returned to normal values within 1 year in
65% of such patients. It was shown that there was right ventricular fractional shortening and improvement in systolic
functions, as assessed by the Tei index, after balloon valvuloplasty in patients with mitral stenosis.In addition,
significant rise in FAC and TAPSE and decrease in PASP was noted post BMV 6 months, which indicates improved RV
function. In the current study RV MPI, S’ showed no significant change after BMV. This lack of immediate
improvement in RV MPI, S’ may be due to effects of sustained pressure overload on the RV for prolonged periods and
these might have shown improvement over longer follow up [5]. This again is concordant with the observation by
Mohan et al [9]who showed that RV MPI shows no immediate change after BMV. RV MPI is a relatively load
independent parameter of the global RV function, which may not change immediately after BMV. There is change in
afterload immediately post BMV, which results in improvement in most of the load dependent parameters.We also
found that there was minor improvement in LV ejection fraction. This correlated with the findings in an earlier study by
Mohan et al [13].The exact reason for this immediate improvement is unclear, but improvement in the atrial
contribution to LV filling, improved myocardial contractilityn may be the possible explanations[14–15].

CONCLUSIONS

This study showed RV function parameters in patients with severe mitral stenosis did not improve immediately after
PTMC. However these parameters showed improvement compared to baseline at 6 months of follow up. The study bearing
with certain limitations this study had a small sample size of 50 patients. Follow up was limited to 6 months. Hence some

Impact Factor (JCC): 5.9089 NAAS Rating 3.99


RV Function Assessment Pre and Post PTMC in Patients with Severe Mitral Stenosis 43

parameters of RV function might have showed improvement in long term follow up. Inadequate image quality in some
patients can be responsible for errors of measurement as RV is difficult to image.

REFERENCES

1. E Nagel, M Stuber, O.M Hass Importance of the right ventricle in valvular heart disease; Eur Heart J, 17 (1996),
pp. 829–836.

2. W Burger, G.D Kneissl, G Kober, R Schrader; Effect of balloon valvuloplasty for mitral stenosis on right
ventricular function; Am J Cardiol, 71 (1993), pp. 994–996.

3. W Burger, S Illert, C Teupe, G.D Kneissl, G Kober, R Schrader; Right ventricular function in patients with mitral
valve stenosis. Effect of balloon mitral valvuloplasty; Z Kardiol, 82 (1993), pp. 545–551.

4. N Hirata, T Sakakibara, Y Shimazaki, et al.; Pre-operative and post-operative right ventricular function during
exercise in patients with mitral stenosis; J Thorac Cardiovasc Surg, 104 (1992), pp. 1025–1034.

5. Vipin Kumar, V. Jacob Jose, Purendra Kumar Pati, John Jose; Assessment of right ventricular strain and strain
rate in patients with severe mitral stenosis before and after balloon mitral valvuloplasty; Indian Heart Journal
66(2014)176e182

6. S.N. Murthy Jayanthi Sriram et al. / IJC Heart & Vasculature 6 (2015) 66–70.

7. Sinan İnci, Mustafa Kemal Erol1, Eftal Murat Bakırcı et al; Effect of percutaneous mitral balloon valvuloplasty
on right ventricular functions in mitral stenosis: Short- and mid term results; Anadolu Kardiyol Derg 2015;
15(0): 000-000.

8. Ahmad Noor, Tahir Saghir and Khan Shah-e-Zaman; Determinants of Decrease in Pulmonary Hypertension
Following Percutaneous Transvenous Mitral Commissurotomy; Journal of The College of Physicians and
Surgeons Pakistan 2009, Vol. 19 (2): 81-85.

9. Mohan JC, Sengupta PP, Arora R. Immediate and delayed effects of successful percutaneous transvenous mitral
commissurotomy on global right ventricular function in patients with isolated mitral stenosis. Int J
Cardiol.1999;68:217e223.

10. Unterberg R, Konig S, Volker W, Pietsch-Breitfeld B, Karsch KR. Function of the right ventricle in patients with
mitral valve diseases. Z Kardiol. 1989;78:386e393.

11. Harvey RM, Ferrer I, Samet P, et al. Mechanical and myocardial factors in rheumatic heart disease with mitral
stenosis. Circulation. 1955;11:531e551.

12. Malhotra V, Beohar PC, Gondal R, Kaul UA, Khanna SK. An autopsy study of rheumatic heart disease. Part II.
Associated findings. Jpn Heart J. 1987;28:7e14.

13. Mohan JC, Bhargava M, Agrawal R, Arora R. Effects of balloon mitral valvuloplasty on left ventricular muscle
function. Int J Cardiol. 1995;49:17e24.

14. Mohan JC, Agrawal R, Arora R, Khalilullah M. Atrial contribution to left ventricular filling in mitral stenosis:
effects of balloon mitral valvuloplasty. Indian Heart J. 1994;46:129e132.

www.iaset.us [email protected]
44 Shilpa Jayaprakash & Kishan Aralapuram

15. Pan JP, Chen CY, Hsu TL, Wang SP, Chiang BN, Chang MS. Response of left ventricular ejection performance
following balloon valvuloplasty in patients with mitral stenosis. Zhonghua Yi Xue Za Zhi (Taipei). 1992; 49: 303e312.

16. Abdenasser Drighil, Ahmed Bennis, James W. Mathewson, Patrizio Lancelotti, Paulo Rocha; Immediate impact of
successful percutaneous mitral valve commissurotomy on right ventricular function; European Journal of
Echocardiography (2008) 9, 536–541.

17. Hayashi J, Okazaki H, Nakazawa S, Watanabe H, Miyamura H, Eguchi S. Right ventricular systolic performance
before and after surgery for tricuspid regurgitation associated with mitral stenosis. Jpn Circ J 1996; 60:96–101.

18. Fawzy ME, Hegazy H, Shoukri M, El-Shaer F, El-Dali A, Al-Amri M. Long-term clinical and echocardiographic
results after successful mitral balloon valvotomy and predictors of long-term outcome. Eur Heart J 2005;
26:1647–52.

19. Harvey RM, Ferrer I, Samet P, et al. Mechanical and myocardial factors in rheumatic heart disease with mitral
stenosis. Circulation. 1955;11: 531e551.

20. Malhotra V, Beohar PC, Gondal R, Kaul UA, Khanna SK. An autopsy study of rheumatic heart disease. Part II.
Associated findings. Jpn Heart J. 1987;28:7e14.

21. Nelson B. Schiller, Damon M. Kwan, The Tei Index as an Expression of Right Ventricular Impairment and
Recovery; Jacc :Cardiovascularimaging;VOL.2, NO.2,2009.

22. Kenneth D. Horton, Rick W. Meece, and Jeffrey C. Hill, Assessment of the Right Ventricle by Echocardiography:
A Primer for Cardiac Sonographers; Journal of the American Society of Echocardiography Volume 22 Number 7.

Impact Factor (JCC): 5.9089 NAAS Rating 3.99

You might also like